Literature DB >> 19622779

Understanding estrogen action during menopause.

Jameel Iqbal1, Mone Zaidi.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19622779      PMCID： PMC2717878          DOI： 10.1210/en.2009-0449

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  28 in total

Review 1.  The protective effects of estrogen on the cardiovascular system.

Authors:  M E Mendelsohn; R H Karas
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

2.  FSH directly regulates bone mass.

Authors:  Li Sun; Yuanzhen Peng; Allison C Sharrow; Jameel Iqbal; Zhiyuan Zhang; Dionysios J Papachristou; Samir Zaidi; Ling-Ling Zhu; Beatrice B Yaroslavskiy; Hang Zhou; Alberta Zallone; M Ram Sairam; T Rajendra Kumar; Wei Bo; Jonathan Braun; Luis Cardoso-Landa; Mitchell B Schaffler; Baljit S Moonga; Harry C Blair; Mone Zaidi
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

3.  Lessons learned from the WHI: HRT requires a cautious and individualized approach.

Authors:  Mira Aubuchon; Nanette Santoro
Journal:  Geriatrics       Date:  2004-11

Review 4.  Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.

Authors:  Pamela Ouyang; Erin D Michos; Richard H Karas
Journal:  J Am Coll Cardiol       Date:  2006-04-17       Impact factor: 24.094

5.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Authors:  Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; Lieling Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick
Journal:  JAMA       Date:  2007-04-04       Impact factor: 56.272

6.  Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation.

Authors:  Jameel Iqbal; Li Sun; T Rajendra Kumar; Harry C Blair; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

Review 7.  The tragedy of TRIUMPH for nitric oxide synthesis inhibition in cardiogenic shock: where do we go from here?

Authors:  Alison Bailey; Theodore W Pope; Scott A Moore; Charles L Campbell
Journal:  Am J Cardiovasc Drugs       Date:  2007       Impact factor: 3.571

8.  Cell-specific effects of nitric oxide deficiency on parathyroid hormone-related peptide (PTHrP) responsiveness and PTH1 receptor expression in cardiovascular cells.

Authors:  Rolf Schreckenberg; Sibylle Wenzel; Rui Manuel da Costa Rebelo; Anja Röthig; Rainer Meyer; Klaus-Dieter Schlüter
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

9.  Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way.

Authors:  Ilhan Tastan; Rolf Schreckenberg; Solaiman Mufti; Yaser Abdallah; Hans Michael Piper; Klaus-Dieter Schlüter
Journal:  Cardiovasc Res       Date:  2009-01-24       Impact factor: 10.787

10.  Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.

Authors:  Marc-Michael Zaruba; Bruno C Huber; Stefan Brunner; Elisabeth Deindl; Robert David; Rebekka Fischer; Gerald Assmann; Nadja Herbach; Sebastian Grundmann; Ruediger Wanke; Josef Mueller-Hoecker; Wolfgang-Michael Franz
Journal:  Cardiovasc Res       Date:  2007-11-30       Impact factor: 10.787
View more
  8 in total

1.  Further evidence that FSH causes bone loss independently of low estrogen.

Authors:  Jameel Iqbal; Harry C Blair; Alberta Zallone; Li Sun; Mone Zaidi
Journal:  Endocrine       Date:  2012-02-21       Impact factor: 3.633

2.  From the gut to the strut: where inflammation reigns, bone abstains.

Authors:  Jameel Iqbal; Tony Yuen; Li Sun; Mone Zaidi
Journal:  J Clin Invest       Date:  2016-04-25       Impact factor: 14.808

Review 3.  Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity.

Authors:  Matthew C Walsh; Noriko Takegahara; Hyunsoo Kim; Yongwon Choi
Journal:  Nat Rev Rheumatol       Date:  2018-01-11       Impact factor: 20.543

4.  Denosumab for the treatment of osteoporosis.

Authors:  Jameel Iqbal; Li Sun; Mone Zaidi
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

5.  Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.

Authors:  Ling-Ling Zhu; Harry Blair; Jay Cao; Tony Yuen; Rauf Latif; Lida Guo; Irina L Tourkova; Jianhua Li; Terry F Davies; Li Sun; Zhuan Bian; Clifford Rosen; Alberta Zallone; Maria I New; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

6.  Age at menopause and incident heart failure: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Imo A Ebong; Karol E Watson; David C Goff; David A Bluemke; Preethi Srikanthan; Tamara Horwich; Alain G Bertoni
Journal:  Menopause       Date:  2014-06       Impact factor: 2.953

Review 7.  The role of sexual dimorphism in susceptibility to SARS-CoV-2 infection, disease severity, and mortality: facts, controversies and future perspectives.

Authors:  Stavroula Pegiou; Elpiniki Rentzeperi; Theocharis Koufakis; Symeon Metallidis; Kalliopi Kotsa
Journal:  Microbes Infect       Date:  2021-06-12       Impact factor: 2.700

8.  The Role of Estriol and Estrone in Keratoconic Stromal Sex Hormone Receptors.

Authors:  Paulina Escandon; Sarah E Nicholas; Rebecca L Cunningham; David A Murphy; Kamran M Riaz; Dimitrios Karamichos
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.